Clark Estates Inc Abb Vie Inc. Transaction History

Clark Estates Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$137.62 - $174.96 $4.18 Million - $5.32 Million	-30,400 Reduced 37.81%	50,000 $7.66 Million
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $3.55 Million - $4.4 Million	-26,900 Reduced 25.07%	80,400 $13 Million
Q1 2021 May 14, 2021	BUY	$102.3 - $112.62 $398,970 - $439,218	3,900 Added 3.77%	107,300 $11.6 Million
Q4 2020 Feb 09, 2021	BUY	$80.49 - $108.67 $1.25 Million - $1.68 Million	15,500 Added 17.63%	103,400 $11.1 Million
Q3 2020 Nov 05, 2020	BUY	$85.91 - $100.83 $1.85 Million - $2.17 Million	21,500 Added 32.38%	87,900 $7.7 Million
Q2 2020 Aug 05, 2020	BUY	$73.37 - $98.18 $1.35 Million - $1.81 Million	18,400 Added 38.33%	66,400 $6.52 Million
Q2 2019 Aug 01, 2019	BUY	$65.7 - $83.98 $3.15 Million - $4.03 Million	48,000 New	48,000 $3.49 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Clark Estates Inc, based on Form 13F filings with the SEC.

Stay updated on Clark Estates Inc with notifications on news.